Doctor Mahendra Sibartie
Amgen, Uxbridge (United Kingdom of Great Britain & Northern Ireland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
High long-term persistence to evolocumab treatment regimens in European clinical practice: analysis of the HEYMANS registry
Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session: Current issues in lipid-lowering therapy
ESC 365 is supported by
